| 000 | 01613 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513131238.0 | ||
| 264 | 0 | _c19971209 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 024 | 7 |
_a10.1038/sj.leu.2400001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNiitsu, N | |
| 245 | 0 | 0 |
_aTHP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin's lymphoma in elderly patients: a prospective study. _h[electronic resource] |
| 260 |
_bLeukemia _cNov 1997 |
||
| 300 |
_a1817-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 |
_aProcarbazine _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aUmeda, M | |
| 773 | 0 |
_tLeukemia _gvol. 11 _gno. 11 _gp. 1817-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2400001 _zAvailable from publisher's website |
| 999 |
_c9339337 _d9339337 |
||